Joshua Britten
Foot & Ankle Surgery · Erie, PANPI 1023274230
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 80.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $914 and has fallen 75.7% since, to $222 in 2025.
Across 176 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Kerecis Limited$206
- Organogenesis Inc.$201
- Stryker$141
- Arthrex$90
- Misonix Inc$25
- plus $46 from 3 others
What the payments were for
- Food & beverage$3,688100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 162 | $2,995 |
| Kerecis Limited | 2 | $206 |
| Organogenesis Inc. | 3 | $201 |
| Stryker | 3 | $141 |
| Arthrex | 1 | $90 |
| Misonix Inc | 2 | $25 |
| Polynovo North America LLC | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $16 |
| Osiris Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$448
- Kerecis Omega3 GraftGuide$149
- Kerecis Omega3 Marigen$149
- GRAFIX PL$129
- Oasis$129
- Affinity$118
How this compares
$3,705 in reported general payments places this provider in the 60th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 87 | $1,663 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $702 |
| Ciclopirox | 33 | $686 |
| Ammonium Lactate | 47 | $678 |
| Ketoconazole | 17 | $412 |
| Diclofenac Sodium | 13 | $337 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $321 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $317 |
| Terbinafine Hcl | 28 | $279 |
| Cephalexin | 40 | $266 |
| Pregabalin | 16 | $209 |
| Triamcinolone Acetonide | 27 | $128 |
| Methylprednisolone | 22 | $126 |
| Doxycycline Hyclate | 14 | $96 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $92 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Erie
- Anthony ColonnaErie$38K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- Jason MillerMalvern$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.